MITA commends House for passage of TPA legislation

Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today commended the U.S. House of Representatives for passing the Trade Promotion Authority (TPA) legislation, which ensures the United States secures the most effective trade agreements possible to advance medical imaging and patient access to care.

“As markets continue to expand around the world, creating further demand for medical imaging equipment, MITA is hopeful that the TPA legislation will improve the global regulatory environment and ensure that American manufacturers stay at the forefront of innovation for the benefit of millions of patients,” said Andy Dhokai, MITA’s Director of Federal Relations.

The bill was brought to the House floor under the leadership of House Ways and Means Committee Chairman Paul Ryan (R-WI) and comes on the heels of TPA legislation that passed in the Senate at the end of last month.

MITA is currently working with U.S. regulators and negotiators on medical imaging equipment provisions in the pending Trans Pacific Partnership (TPP) and the Trans-Atlantic Trade and Investment Partnership (TTIP) agreements. Passage of the TPA will enable the TPP and TTIP agreements to move forward, so in turn medical imaging manufacturers and other American companies will be able to hire more American workers, pay competitive wages, and help grow local economies. The TPA negotiating objectives provide that negotiators reach trade agreements with regulatory transparency and accountability.

###

MITA, a division of the National Electrical Manufacturers Association (NEMA), is the collective voice of medical imaging equipment, radiation therapy and radiopharmaceutical manufacturers, innovators and product developers. It represents companies whose sales comprise more than 90 percent of the global market for medical imaging technology. For more information, visit www.medicalimaging.org. Follow MITA on Twitter @MITAToday.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.